Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "scientific outlook"

Agilent Profit Tops Estimate; Outlook Weak
RTTNews.com

Agilent Profit Tops Estimate; Outlook Weak

Scientific instruments maker Agilent Technologies Inc. (A) said Monday after the markets closed that its third quarter profit fell 30% from last year, when profit was boosted by results from its electronic measurement business that was spun off as ... RTTNews.com, 1 week ago

Boston Scientific Q2 Profit Soars, Ups 2015 Sales Outlook - Quick Facts

(RTTNews.com) - Medical devices maker Boston Scientific Corp. ( BSX ) reported net earnings of $102 million or $0.08 per share for the second quarter, sharply higher than $4 million or breakeven per share in the prior-year quarter. Results for the ...
 Nasdaq1 month ago Stryker, St. Jude, Boston Scientific's Q2 Sales Rise  Medical Design Online1 month ago

BOSTON SCIENTIFIC : Despite dip in sale of key devices, Boston Scientific upbeat on outlook

July 24 -- Boston Scientific Corp. saw a drop in U.S. sales of core heart-rhythm devices like pacemakers and defibrillators in the last quarter -- and the trend is expected to continue for the rest of the year. But executives remain upbeat about ...
 4 Traders1 month ago Despite dip in sale of key devices, Boston Scientific upbeat on outlook [Star Tribune (Minneapolis)]  Bloomberg1 month ago

Thermo Fisher Scientific Lifts Full Year Outlook

By Maria Armental And Chelsey Dulaney Thermo Fisher Scientific Inc. on Wednesday lifted its full-year earnings and revenue guidance as profit nearly doubled in its second quarter. The Massachusetts biotechnology company said it now expects to ...
 4 Traders1 month ago
[x]  
The Pew Charitable Trusts

Scientists Say Outlook for Pacific Bluefin Is Worse Than Previously Thought

Bluefin tuna swimming. It is widely accepted by governments , industry , and nongovernmental organizations that Pacific bluefin tuna are in a dire state. A new analysis conducted by Japanese scientists provides further evidence that the bluefin ...
 The Pew Charitable Trusts1 month ago Bluefin tuna outlook worse than first thought  World Fishing1 month ago

Promotion of Scientific Outlook among Students

Press Information Bureau Government of India Ministry of Human Resource Development 22-July-2015 16:12 IST Promotion of Scientific Outlook
 Noodls1 month ago
Seeking Alpha

Ocata Therapeutics: Insider Enrichment, Failed Science, Long History Of Fraud Ties, 77% Downside

cs, Inc. (OCAT), Includes: ATRS, BHRT, ENZN, GALE, PBIO, UNIS by: Mako Research Summary Ocata's RPE stem cell therapy trials are dubious at best and research indicates are highly likely to cause tumors. Ocata has a long history of ties to ...
 Seeking Alpha1 week ago
Seeking Alpha

Thermo Fisher Scientific Inc.: Portfolio Selection Using Reduced Form Default Probabilities

Jul. 23, 2015 2:46 PM ET | About: Thermo Fisher Scientific Inc. (TMO) by: Summary Many institutional and retail investors have used legacy credit ratings for so long that the use of modern default probabilities for portfolio selection is new ...
 Seeking Alpha1 month ago Thermo Fisher Scientific achieves 7% growth in adjusted EPS in Q2 2015  Bloomberg1 month ago
Rediff.com

'Why and how did science in India stagnate?'

'Indian ganita predictions were as good as or better than the best elsewhere.' 'The debate between mythology and "rational" science in India is at least as old as Aryabhata and Brahmagupta and, to this day, has not been resolved in the Indian popular thinking on science.' Professor Roddam Narasimha, FRS, is a distinguished aerospace scientist and among the first few Indian engineers to be elected to several leading international academies like the Royal Society, the US National Academies of ...
 Rediff.com2 weeks ago
Octafinance

New York: Relx (NYSE:RELX) Rating Outlook Improved to Buy by Berenberg. Lost Its Hold Rating

Relx (NYSE:RELX) Upgrade of Rating Stock research analysts at Berenberg's equity division raised Relx (NYSE:RELX)'s stock from Hold to Buy on Thursday, 27 August. The stock upgrade is well-received by stock investors, as NYSE:RELX is right now ...
 Octafinance2 days ago New York: Roper Industries (NYSE:ROP) Rating Outlook Improved to sell at Zacks. Lost Its hold Rating  Octafinance1 week ago Roper Industries Q2 Adj. Profit Tops View, But Sales Miss; Trims 2015 Outlook  RTTNews.com1 month ago Roper Technologies (ROP) Stock Falls on Earnings Results, Guidance  TheStreet.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less